Loading publications…
The last 5 uploaded publications
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial
Margaretha Prins, Geert V.T. Roozen, Cilia R. Pothast, Wesley Huisman, Rob van Binnendijk, Gerco den Hartog, Vincent P. Kuiper, Corine Prins, Jacqueline J. Janse, Olivia A. C. Lamers, Jan Pieter R. Koopman, Annelieke C. Kruithof, Ingrid M. C. Kamerling, Romy C. Dijkland, Alicia C. de Kroon, Shohreh Azimi, Mariet C.W. Feltkamp, Marjan Kuijer, Simon P. Jochems, Mirjam H.M. Heemskerk, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H.E. Roukens (2024). Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial. npj Vaccines, 9(1), DOI: 10.1038/s41541-023-00785-w.
Article126 days agoSafety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study
Geert V.T. Roozen, Margaretha Prins, Rob van Binnendijk, Gerco den Hartog, Vincent P. Kuiper, Corine Prins, Jacqueline J. Janse, Annelieke C. Kruithof, Mariet C.W. Feltkamp, Marjan Kuijer, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H.E. Roukens (2022). Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study. Annals of Internal Medicine, 175(12), pp. 1771-1774, DOI: 10.7326/m22-2089.
Article126 days agoCoagulation and inflammatory response after intramuscular or intradermal mRNA-1273 SARS-CoV-2 vaccine: secondary analysis of a randomized trial
Willian van Dijk, Margaretha Prins, Anna H.E. Roukens, Geert V.T. Roozen, Meta Roestenberg, Leo G. Visser, Astrid van Hylckama Vlieg, Frits R. Rosendaal (2024). Coagulation and inflammatory response after intramuscular or intradermal mRNA-1273 SARS-CoV-2 vaccine: secondary analysis of a randomized trial. Research and Practice in Thrombosis and Haemostasis, 8(3), pp. 102419-102419, DOI: 10.1016/j.rpth.2024.102419.
Article126 days agoTolerability, safety and immunogenicity of intradermal delivery of a fractional dose mRNA-1273 SARS-CoV-2 vaccine in healthy adults as a dose sparing strategy
Geert V.T. Roozen, Margaretha Prins, Rob van Binnendijk, Gerco den Hartog, Vincent P. Kuiper, Corine Prins, Jacqueline J. Janse, Annelieke C. Kruithof, Mariet C.W. Feltkamp, Marjan Kuijer, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H.E. Roukens (2021). Tolerability, safety and immunogenicity of intradermal delivery of a fractional dose mRNA-1273 SARS-CoV-2 vaccine in healthy adults as a dose sparing strategy. medRxiv (Cold Spring Harbor Laboratory), DOI: 10.1101/2021.07.27.21261116.
Preprint126 days ago